Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly
Trial Details
- NCT ID
- NCT06712420
- Phase
- PHASE3
- Sponsor
- Rajiv Gandhi Cancer Institute & Research Center, India
- Status
- RECRUITING
- Cancer Type
- Bladder Cancer
- Interventions
- neoadjuvant chemotherapy
- curative surgery
- Locations (sample)
- Delhi, National Capital Territory of Delhi, India|28.65195,77.23149
- Delhi, National Capital Territory of Delhi, India|28.65195,77.23149
- Delhi, National Capital Territory of Delhi, India|28.65195,77.23149
Key Eligibility Criteria
- Locally advanced resectable GBC defined as Clinical T3/4 disease or Regional LN involvement on imaging studies.
- Post cholecystectomy GBC with residual disease on imaging, History of bile spillage during primary surgery , history of piece-meal removal of gall …
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Bladder Cancer Trials on Trialify →